Status:
COMPLETED
Techniques to Improve Efficacy of Second Trimester Medical Termination
Lead Sponsor:
King Edward Memorial Hospital
Conditions:
Pregnancy
Eligibility:
FEMALE
16-50 years
Phase:
NA
Brief Summary
Interruption of a pregnancy after 14 weeks gestation may be required when the fetus is dead, severely malformed or in cases of maternal illness. This process is usually conducted medically in Australi...
Detailed Description
Aims: 1. To compare the efficacy of the vaginal and sublingual administration of the synthetic prostaglandin misoprostol with the currently used vaginal administration route in second trimester pregn...
Eligibility Criteria
Inclusion
- 14-24 weeks pregnant
- planned medical termination
- able to speak and understand English
- no contraindication to prostaglandins
Exclusion
- gestation \< 13 weeks
- allergy/contraindication to misoprostol
- allergy/contraindication to mifepristone
- fetal demise
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT00864799
Start Date
April 1 2009
End Date
March 1 2013
Last Update
July 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Edward Memorial Hospital
Perth, Western Australia, Australia, 6008